While gastric bypass surgery remains popular as the only treatment for morbid obesity with curative potential, the molecular mechanisms underpinning its immediate metabolic benefits remain unclear. New work in this issue (Troy et al., 2008) suggests intestinal glucose production sensed by afferent nerve fibers surrounding the portal vein may be key
A rapid remission of type 2 diabetes mellitus occurs after gastric bypass surgery in the morbidly ob...
International audienceObjective: Roux-en-Y gastric surgery (RYGB) promotes a rapid and sustained wei...
AbstractGLP-1 secretion in response to meals is dramatically increased after gastric bypass operatio...
While gastric bypass surgery remains popular as the only treatment for morbid obesity with curative ...
Bariatric surgical procedures such as vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass...
SummaryUnlike the adjustable gastric banding procedure (AGB), Roux-en-Y gastric bypass surgery (RYGB...
The obesity crisis has reached epidemic proportions. Medical therapies are few and far between, offe...
OBJECTIVE Roux-en-Y gastric bypass (RYGB) characteristically enhances postprandial levels of glucago...
Background: Despite of its significant therapeutic effects on obesity and metabolic diseases, Roux-e...
Obesity has reached epidemic proportions and, to date, bariatric surgery remains the only effective ...
Obesity is becoming the healthcare epidemic of this century. Weight loss surgery is the only effecti...
At the 2nd Diabetes Surgical Summit in 2015, the world’s leading researchers and professionals in th...
Emerging evidence suggests the gastrointestinal tract plays an important glucoregulatory role. In th...
In the past, weight loss surgery was often perceived as cosmetic surgery as it was primarily aiming ...
AbstractBackgroundThe reported remission of type 2 diabetes in patients undergoing Roux-en-Y gastric...
A rapid remission of type 2 diabetes mellitus occurs after gastric bypass surgery in the morbidly ob...
International audienceObjective: Roux-en-Y gastric surgery (RYGB) promotes a rapid and sustained wei...
AbstractGLP-1 secretion in response to meals is dramatically increased after gastric bypass operatio...
While gastric bypass surgery remains popular as the only treatment for morbid obesity with curative ...
Bariatric surgical procedures such as vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass...
SummaryUnlike the adjustable gastric banding procedure (AGB), Roux-en-Y gastric bypass surgery (RYGB...
The obesity crisis has reached epidemic proportions. Medical therapies are few and far between, offe...
OBJECTIVE Roux-en-Y gastric bypass (RYGB) characteristically enhances postprandial levels of glucago...
Background: Despite of its significant therapeutic effects on obesity and metabolic diseases, Roux-e...
Obesity has reached epidemic proportions and, to date, bariatric surgery remains the only effective ...
Obesity is becoming the healthcare epidemic of this century. Weight loss surgery is the only effecti...
At the 2nd Diabetes Surgical Summit in 2015, the world’s leading researchers and professionals in th...
Emerging evidence suggests the gastrointestinal tract plays an important glucoregulatory role. In th...
In the past, weight loss surgery was often perceived as cosmetic surgery as it was primarily aiming ...
AbstractBackgroundThe reported remission of type 2 diabetes in patients undergoing Roux-en-Y gastric...
A rapid remission of type 2 diabetes mellitus occurs after gastric bypass surgery in the morbidly ob...
International audienceObjective: Roux-en-Y gastric surgery (RYGB) promotes a rapid and sustained wei...
AbstractGLP-1 secretion in response to meals is dramatically increased after gastric bypass operatio...